Precision medicine unlocks access to standard of care and experimental therapies with the promise of improving outcomes and advancing cancer care for everyone.
In this panel, clinical leaders from three community oncology practices discuss discuss challenges and opportunities of precision medicine, and the many ways practices are helping to enable this cutting edge treatment for every patient.
Nate Wade, PharmD, MSBA, BCOP Associate Director, Clinical Oncology Flatiron Health
Ari VanderWalde, MD, MPH, MBioeth, FACP Director of Research, West Cancer Center & Research Institute
Jonas Congelli, RPh Chief of Pharmacy and Ancillary Services, Hematology Oncology Associates of Central New York
Lucio Gordan, MD President & Managing Physician, Florida Cancer Specialists and Research Institute